Home › Funds › VISION FINANCIAL MARKETS LLC › SLS
VISION FINANCIAL MARKETS LLC position in SLS
SELLAS LIFE SCIENCES GROUP INC COM NEW · Health Care
VISION FINANCIAL MARKETS LLC reported holding 57,000 shares of SLS (SELLAS LIFE SCIENCES GROUP INC COM NEW) in its Q3 2026 13F filing — a position valued at US$702K, representing 0.53% of its reported portfolio and ranking #29 among its reported holdings. VISION FINANCIAL MARKETS LLC has disclosed SLS holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-10-22 · Source: SEC EDGAR Form 13F-HR
How VISION FINANCIAL MARKETS LLC's SLS position evolved
VISION FINANCIAL MARKETS LLC first disclosed a stake in SLS in Q1 2026 at 304,400 shares (US$1.3M). Across 3 filings, VISION FINANCIAL MARKETS LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 57,000 shares valued at US$702K — an increase of 47,200 shares quarter over quarter.. Notable position changes include a 97% trim in Q2 2026 (shares fell 17% over the following quarter), a 482% increase in Q3 2026 (shares fell 28% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 304.40K | $1.29M | New |
| Q2 2026 | 9.80K | $144.65K | Reduce |
| Q3 2026 | 57.00K | $701.67K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SLS and 13F data
SLS (SELLAS LIFE SCIENCES GROUP INC COM NEW) is a Health Care company. 129 other funds we track also report a position in SLS — the largest reported positions include DAGCO, INC. (US$18.2M), Sio Capital Management, LLC (US$18.2M), Anson Funds Management LP (US$11.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SLS
- DAGCO, INC. 1.23M sh · $18.19M · Q2 2026
- Sio Capital Management, LLC 1.23M sh · $18.17M · Q2 2026
- Anson Funds Management LP 800.00K sh · $11.81M · Q2 2026
- Opus Capital Group, LLC 385.60K sh · $5.69M · Q2 2026
- Ikarian Capital, LLC 354.70K sh · $5.24M · Q2 2026
- Rosalind Advisors, Inc. 568.70K sh · $2.30M · Q2 2026
- FULCRUM WEALTH ADVISORS, LLC 85.45K sh · $1.05M · Q3 2026
- INSTRUMENTAL WEALTH, LLC 44.91K sh · $662.93K · Q2 2026
More on VISION FINANCIAL MARKETS LLC
FAQ
How long has VISION FINANCIAL MARKETS LLC held SLS?
VISION FINANCIAL MARKETS LLC has disclosed SLS holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is VISION FINANCIAL MARKETS LLC's current position in SLS?
As of Q3 2026, VISION FINANCIAL MARKETS LLC holds 57.00K shares of SLS (SELLAS LIFE SCIENCES GROUP INC COM NEW), valued at $701.67K, representing 0.53% of its reported portfolio and ranking #29.
Has VISION FINANCIAL MARKETS LLC been buying or selling SLS?
In the latest 13F filing (Q3 2026), VISION FINANCIAL MARKETS LLC increased its position in SLS.
Which other funds hold SLS?
Other major institutional holders of SLS include DAGCO, INC., Sio Capital Management, LLC, Anson Funds Management LP, among 129 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.